1. All of the plaintiff's claims are dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. On January 8, 2007, the Defendant established C (hereinafter “C”) in order to produce and sell the anesthesia fastening apparatus of anesthesia patients developed by himself, and acquired the patent right listed in the attached Form (hereinafter “instant patent right”) on the D date, and around March 2008, the Plaintiff agreed to take exclusive charge of management by acquiring 50% of the shares C from the Defendant.

[Grounds for recognition] The descriptions of evidence Nos. 1 and 7, and the purport of the whole pleadings

2. The parties' assertion

A. The plaintiff's assertion 1) The defendant has a patent for the anesthesia fixed apparatus, which is the anesthesia and medical equipment that the plaintiff developed. The defendant transferred the above patent to a corporation established by the defendant, and it is expected that the plaintiff will own it as a corporation and sell products, and he must concurrently engage in the business as a doctor. Thus, the plaintiff must take charge of the plaintiff's management and pay 50 million won of shares to the plaintiff, and pay 100 million won of shares to the plaintiff through E, which is the plaintiff's trust and will pay 200 million won of shares by raising the remaining 10 million won of shares through other investors, and the plaintiff paid 200 million won of shares to the defendant by raising 10 million won of shares through other investors, and the plaintiff's complaint established by the defendant to "G," but the plaintiff seems to have been "A corporation's share transfer to 100 million won of shares in the patent right in this case, in light of each of the Gap evidence Nos. 4 and 5-1 and 2'C's shares in this case.

3 Preliminary claim is not subject to medical insurance and sales.